Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Power

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 2, 2016
Multiparametric magnetic resonance imaging for pre-treatment local staging of prostate cancer: A Cancer Care Ontario clinical practice guidelineJennifer Salerno, Antonio Finelli, Chris Morash, et al.
European Urology|December 14, 2011
Comparison of open and minimally invasive partial nephrectomy for renal tumors 4-7 centimetersPreston C Sprenkle, Nicholas Power, Tarek Ghoneim, et al.
The Journal of Urology|February 9, 2013
Urine neutrophil gelatinase-associated lipocalin as a marker of acute kidney injury after kidney surgeryPreston C Sprenkle, James Wren, Alexandra C Maschino, et al.
Urologic Oncology|March 9, 2021
Expression of programmed death ligand-1 (PD-L1) in metastatic and postchemotherapy viable testicular germ cell tumorsMofarej Al-Hogbani, Jérémie Duguay, Daniel-Christoph Wagner, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 27, 2017
Chemoradiotherapy in octogenarians as primary treatment for muscle-invasive bladder cancerVictor A McPherson, George Rodrigues, Glenn Bauman, et al.
Molecular and Cellular Biology|May 4, 2016
Fibroblast Growth Factor Receptor-Dependent and -Independent Paracrine Signaling by Sunitinib-Resistant Renal Cell CarcinomaTram Anh Tran, Hon Sing Leong, Andrea Pavia-Jimenez, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 26, 2022
European society of clinical microbiology and infectious diseases guidelines for coronavirus disease 2019: an update on treatment of patients with mild/moderate diseaseMichele Bartoletti, Ozlem Azap, Aleksandra Barac, et al.
JAMA Internal Medicine|June 25, 2019
Decision Aids for Prostate Cancer Screening Choice: A Systematic Review and Meta-analysisJarno M Riikonen, Gordon H Guyatt, Tuomas P Kilpeläinen, et al.
European Urology Focus|February 12, 2018
A New Model to Predict Benign Histology in Residual Retroperitoneal Masses After Chemotherapy in NonseminomaRicardo Leão, Madhur Nayan, Nahid Punjani, et al.
European Urology Focus|November 5, 2021
Outcomes of Cytoreductive Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Real World Data from Canadian CentersAlice Dragomir, Sara Nazha, Simon Tanguay, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 2, 2016
Multiparametric magnetic resonance imaging for pre-treatment local staging of prostate cancer: A Cancer Care Ontario clinical practice guidelineJennifer Salerno, Antonio Finelli, Chris Morash, et al.
European Urology|December 14, 2011
Comparison of open and minimally invasive partial nephrectomy for renal tumors 4-7 centimetersPreston C Sprenkle, Nicholas Power, Tarek Ghoneim, et al.
The Journal of Urology|February 9, 2013
Urine neutrophil gelatinase-associated lipocalin as a marker of acute kidney injury after kidney surgeryPreston C Sprenkle, James Wren, Alexandra C Maschino, et al.
Urologic Oncology|March 9, 2021
Expression of programmed death ligand-1 (PD-L1) in metastatic and postchemotherapy viable testicular germ cell tumorsMofarej Al-Hogbani, Jérémie Duguay, Daniel-Christoph Wagner, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 27, 2017
Chemoradiotherapy in octogenarians as primary treatment for muscle-invasive bladder cancerVictor A McPherson, George Rodrigues, Glenn Bauman, et al.
Molecular and Cellular Biology|May 4, 2016
Fibroblast Growth Factor Receptor-Dependent and -Independent Paracrine Signaling by Sunitinib-Resistant Renal Cell CarcinomaTram Anh Tran, Hon Sing Leong, Andrea Pavia-Jimenez, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 26, 2022
European society of clinical microbiology and infectious diseases guidelines for coronavirus disease 2019: an update on treatment of patients with mild/moderate diseaseMichele Bartoletti, Ozlem Azap, Aleksandra Barac, et al.
JAMA Internal Medicine|June 25, 2019
Decision Aids for Prostate Cancer Screening Choice: A Systematic Review and Meta-analysisJarno M Riikonen, Gordon H Guyatt, Tuomas P Kilpeläinen, et al.
European Urology Focus|February 12, 2018
A New Model to Predict Benign Histology in Residual Retroperitoneal Masses After Chemotherapy in NonseminomaRicardo Leão, Madhur Nayan, Nahid Punjani, et al.
European Urology Focus|November 5, 2021
Outcomes of Cytoreductive Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Real World Data from Canadian CentersAlice Dragomir, Sara Nazha, Simon Tanguay, et al.
Pageof 4